Hualan Biological Bacterin Inc. (301207.SZ)
CNY 16.0
(-0.5%)
CNY 16.0
(-0.5%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.11 Billion CNY | 37.8% |
| 2022 | 855.96 Million CNY | 7.82% |
| 2021 | 793.88 Million CNY | -20.92% |
| 2020 | 1 Billion CNY | 171.98% |
| 2019 | 369.09 Million CNY | 15.04% |
| 2018 | 320.84 Million CNY | 20.84% |
| 2017 | 265.51 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 493.24 Million CNY | 6983.26% |
| 2024 Q1 | 50.15 Million CNY | -85.68% |
| 2024 Q2 | 6.6 Million CNY | -86.83% |
| 2023 Q1 | 87.42 Million CNY | 110.48% |
| 2023 FY | 1.17 Billion CNY | 37.8% |
| 2023 Q4 | 350.22 Million CNY | -51.45% |
| 2023 Q3 | 721.32 Million CNY | 1933.17% |
| 2023 Q2 | 35.47 Million CNY | -59.42% |
| 2022 Q3 | 224.74 Million CNY | -59.15% |
| 2022 Q2 | 550.23 Million CNY | 1294.96% |
| 2022 Q1 | 39.44 Million CNY | -73.55% |
| 2022 FY | 855.96 Million CNY | 7.82% |
| 2022 Q4 | 41.53 Million CNY | -81.52% |
| 2021 Q1 | -21.43 Million CNY | -104.14% |
| 2021 Q4 | 149.15 Million CNY | -71.35% |
| 2021 Q3 | 520.68 Million CNY | 1519.39% |
| 2021 Q2 | -36.68 Million CNY | -71.13% |
| 2021 FY | 793.88 Million CNY | -20.92% |
| 2020 FY | 1 Billion CNY | 171.98% |
| 2020 Q4 | 518.38 Million CNY | 18.63% |
| 2020 Q3 | 436.99 Million CNY | 7337.67% |
| 2020 Q2 | -6.03 Million CNY | 76.65% |
| 2020 Q1 | -25.85 Million CNY | 0.0% |
| 2019 FY | 369.09 Million CNY | 15.04% |
| 2018 FY | 320.84 Million CNY | 20.84% |
| 2017 FY | 265.51 Million CNY | 0.0% |